Latest News

  • Walking Patterns May Help Differentiate Between Parkinson’s Disease and Dementia with Lewy Bodies

    Diagnostics World | Early dementia with Lewy bodies (DLB) and early Parkinson’s disease share several symptoms and are often misdiagnosed in early stages. It is critical to accurately distinguish the two diseases because of their contrasting disease paths. Fortunately, walking behaviors may be early diagnostic markers for neurodegeneration.

    Apr 17, 2026

  • Children’s Hospital of Philadelphia and Labcorp Collaborate for Pediatric Diagnosis

    Diagnostics World | Labcorp and the Children’s Hospital of Philadelphia (CHOP) announced this week that they will be entering a collaboration to advance the discovery and development of specialized pediatric diagnostics, as well as expand access to advanced diagnostic testing for children and families across the nation.

    Apr 16, 2026

  • Study Links Executive Functioning to Physical Activity in Older Adults

    Diagnostics World | Researchers in Belgium compared cognition to movement data in healthy adults looking for links that might predict cognitive decline later in life. The study is part of the PASOCA-project (how Physical Activity and Sleep relate to Optimal Cognitive Ageing), a two-year longitudinal, observational study examining 24-hour movement behaviors and cognitive function in cognitively healthy adults aged 55 and older residing in Flanders, Belgium.

    Apr 14, 2026

  • Using Genomics to Tease Apart Racial Disparities in Breast Cancer Outcomes

    Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences.

    Apr 10, 2026

  • Using Genomics to Tease Apart Racial Disparities in Breast Cancer Outcomes

    Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences.

    Apr 10, 2026

  • From Fingertip to Mainstream: Babson Diagnostics Bets Its Decade of Science Is Ready for Prime Time

    Diagnostics World | When Web Golinkin joined Babson Diagnostics as an advisor in mid-2024, he did what experienced healthcare executives do: he listened, watched, and formed a thesis. After eight months advising, a brief stint as president and chief commercial officer, and now one month into the CEO role, his thesis has hardened into conviction.

    Apr 9, 2026

  • The Future of Blood Testing Lies in Understanding the Whole Body

    Diagnostics World | For decades, blood testing innovation has focused on improving patient testing for earlier and faster intervention. Advances in sequencing, automation, and molecular testing have dramatically improved our ability to biologically monitor patients. But as powerful as these technologies have become, they often still operate within a limited framework: they look for a biomarker panel that constitutes a single signal tied to a single disease.

    Apr 3, 2026

  • Handheld AI-Powered Eye Scanner Could Reach More Patients

    Diagnostics World | Research out of Tohoku University in Sendai, Japan, provides a model for easily assessing front of the eye health outside of hospitals. The research team envisions employing the portable AI-powered scanning slit-light device in remote eye-screening camps, elderly-care facilities, pharmacies, or even train stations to make ophthalmic care more accessible, so patients can be assessed any place and any time.

    Apr 2, 2026

  • Roche ApoE4 Blood Test

    Diagnostics World | Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 biomarker test – the first in-vitro diagnostic (IVD) immunoassay to identify the presence of the ApoE4 gene variant in the bloodstream.

    Apr 1, 2026